Tag: metastatic TNBC treatment
FDA Approves Datroway for Metastatic Triple-Negative Breast Cancer
AstraZeneca and Daiichi Sankyo announced that the US Food and Drug Administration (FDA) has approved Datroway(datopotamab deruxtecan) for adult patients with unresectable or metastatic triple-negative breast cancer (TNBC)...